證據(jù)報告：兒童全身性發(fā)育遲緩的基因和代謝檢測
《證據(jù)報告：兒童全身性發(fā)育遲緩的基因和代謝檢測》內(nèi)容預覽
Methods: Relevant literature was reviewed, abstracted, and classified according to the 4-tiered American Academy of Neurology classification of evidence scheme.
Results and Conclusions: In patients with GDD/ID, microarray testing is diagnostic on average in 7.8% (Class III), G-banded karyotyping is abnormal in at least 4% (Class II and III), and subtelo-meric fluorescence in situ hybridization is positive in 3.5% (Class I, II, and III). Testing for X-linked ID genes has a yield of up to 42% in males with an appropriate family history (Class III). FMR1 testing shows full expansion in at least 2% of patients with mild to moderate GDD/ID (Class II and III), and MeCP2 testing is diagnostic in 1.5% of females with moderate to severe GDD/ID (Class III). Tests for metabolic disorders have a yield of up to 5%, and tests for congenital disorders of glycosylation and cerebral creatine disorders have yields of up to 2.8% (Class III). Several genetic and metabolic screening tests have been shown to have a better than 1% diagnostic yield in selected populations of children with GDD/ID. These values should be among the many factors considered in planning the laboratory evaluation of such children.
點擊下載完整版地址：《證據(jù)報告：兒童全身性發(fā)育遲緩的基因和代謝檢測》
本站所注明來源為"愛愛醫(yī)"的文章，版權歸作者與本站共同所有，非經(jīng)授權不得轉(zhuǎn)載。
本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的，且明確注明來源和作者，不希望被轉(zhuǎn)載的媒體或個人可與我們
聯(lián)系zlzs@120.net，我們將立即進行刪除處理
熱點圖文
-
2010HPS蘇格蘭人類狂犬病的預防和管理指南
Health Protection Scotland （HPS） is a...[詳細]
-
狂犬病診斷標準及處理原則
補充水電解質(zhì)及熱量，糾正酸堿平衡失調(diào)；對煩躁不安、痙攣者輪流使用各種鎮(zhèn)靜劑...[詳細]
